Gene Therapies: CoGenT Pilot Could Help With Regulatory Convergence Earlier In Development

The program for collaborative gene therapy reviews with the European Medicines Agency is starting with simple applications, but after launch could be expanded to earlier discussions of CMC and pharm/tox data requirements, the FDA’s Nicole Verdun said.